Letter: association between COVID‐19 and inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter: association between COVID‐19 and inflammatory bowel disease

Published:2022-04-16 Issue:9 Volume:55 Page:1226-1227
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Chen Hui‐Yuan¹^ORCID,Wang Shiow‐Ing²^ORCID,Chang Renin³^ORCID,Wei James Cheng‐Chung¹⁴⁵^ORCID

Affiliation:

1. Institute of Medicine Chung Shan Medical University Taichung Taiwan

2. Center for Health Data Science, Department of Medical Research Chung Shan Medical University Hospital Taichung Taiwan

3. Department of Emergency Medicine Veterans General Hospital Kaohsiung Taiwan

4. Department of Allergy, Immunology and Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

5. Graduate Institute of Integrated Medicine China Medical University Taichung Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16814

Reference6 articles.

1. Incidence, outcomes, and impact of COVID‐19 on inflammatory bowel disease: propensity matched research network analysis

2. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

3. SARS-CoV-2 vaccination in IBD: more pros than cons

4. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient

5. Environmental triggers in IBD: a review of progress and evidence

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of autoimmune diseases in patients with COVID-19 a retrospective cohort study;ECLINICALMEDICINE;2023

2. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study;eClinicalMedicine;2023-02

3. Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis;International Journal of Rheumatic Diseases;2022-10-14

4. Letter: association between COVID ‐19 and inflammatory bowel disease—Authors' reply;Alimentary Pharmacology & Therapeutics;2022-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3